LARGO, Fla., Aug. 14 /PRNewswire-FirstCall/ -- GeoPharma, Inc. , a pharmaceutical company specializing in manufacturing and distributing over-the-counter, nutritional, generic drug and functional food products, announced today that the Company’s CEO, Mihir Taneja, was interviewed on August 3rd, 2006 by the Zangani Investor Community, who have been retained as the company’s Investor Relations firm.
Mr. Taneja highlighted growth strategies for the future of GeoPharma, Inc. To access the interview, please visit the Zangani Investor Community at: http://www.zangani.com/geopharma/2006-0803-gorx
The interview is also available via Podcast at http://www.zangani.com or through the iTunes music store.
About GeoPharma, Inc.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company’s growth strategy is to capitalize on its manufacturing expertise to develop high-margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma’s competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at http://www.geopharmainc.com , http://www.onlineihp.com and http://www.hoodiadexl10.com .
FORWARD-LOOKING STATEMENTS
This press release may contain statements that constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company’s management as of the date hereof, and actual results may vary based upon future events, both within and without management’s control. Important factors that could cause such differences are described in the company’s periodic filings with the Securities and Exchange Commission.
Audio: http://www.zangani.com/geopharma/2006-0803-gorxGeoPharma, Inc.
CONTACT: Carol Dore-Falcone, VP and CFO of GeoPharma, +1-727-544-8866,ext. 244, or cdf@onlineihp.com